The Corn Lab

The Corn Lab develops and uses next-generation genome editing and regulation technologies. We work on both fundamental biological discovery and potential therapies for human genetic diseases. Our focus is the mechanisms by which cells repair their DNA, maintain and differentiate hematopoietic stem cells, and dispose of entire organelles. Through technology development, mechanistic cellular biochemistry, and translational projects, we are working to unravel complex cellular phenotypes to further biological understanding and improve human health.

Our work is supported by the Swiss National Science Foundation, the European Research Council, the NCCR RNA & Disease, the Fanconi Anemia Research Fund, the Bill and Melinda Gates Foundation, the NOMIS Foundation, and the Lotte and Adolf Hotz-Sprenger Foundation.

News

July 9, 2024

CCAR1 PROMOTES DNA REPAIR VIA ALTERNATIVE SPLICING – PUBLISHED IN MOLECULAR CELL

Cells constantly experience DNA damage throughout their lifespan due to a variety of endogenous and exogenous factors. Among the different types of DNA damage,...

July 1, 2024

Latsis Symposium on Genome and Transcriptome Engineering 2024

The Latsis Symposium on Genome and Transcriptome Engineering, held on June 13-14, 2024 in Zurich, was a remarkable event! This dynamic two-day gathering ...

July 1, 2024

D-BIOL Symposium 2024

From June 10-12, 2024, the Corn Lab members attended the 14th D-BIOL Symposium in Davos. This exciting biannual internal ETHZ event brought together nearly...

News Archive

Tweets

Contact Us

Questions and/or comments about Corn Lab and its activities may be addressed to:

JACOB.CORN@BIOL.ETHZ.CH

Share: